169 related articles for article (PubMed ID: 24796328)
1. A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.
Hua F; Fang N; Li X; Zhu S; Zhang W; Gu J
PLoS One; 2014; 9(5):e96163. PubMed ID: 24796328
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review.
Song X; Shi K; Zhou SJ; Yu DP; Liu Z; Han Y
Drug Des Devel Ther; 2016; 10():1345-54. PubMed ID: 27103788
[TBL] [Abstract][Full Text] [Related]
3. Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis.
Gu J; Wen Y; Zhu S; Hua F; Zhao H; Xu H; You J; Sun L; Wang W; Chen J; Zhou Q
PLoS One; 2013; 8(4):e60107. PubMed ID: 23577085
[TBL] [Abstract][Full Text] [Related]
4. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer].
Wei H; Fang N; Guo L; Wu Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870
[TBL] [Abstract][Full Text] [Related]
5. [A meta-analysis of Association between MGMT gene promoter methylation and non-small cell lung cancer].
Fang N; Gu J; Wei H; You J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):601-5. PubMed ID: 25130966
[TBL] [Abstract][Full Text] [Related]
6. Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis.
Wen G; Wang H; Zhong Z
Medicine (Baltimore); 2018 Mar; 97(11):e9971. PubMed ID: 29538221
[TBL] [Abstract][Full Text] [Related]
7. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
[TBL] [Abstract][Full Text] [Related]
9. Association between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature review.
Li Y; Lu DG; Ma YM; Liu H
Oncotarget; 2017 Jan; 8(4):5814-5822. PubMed ID: 28008143
[TBL] [Abstract][Full Text] [Related]
10. Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis.
Hu B; Zhang H; Wei H; Wang Z; Zhang F; Wang X; Li L
Thorac Cancer; 2017 Sep; 8(5):410-416. PubMed ID: 28497891
[TBL] [Abstract][Full Text] [Related]
11. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
Zhang Z; Yan S; Cui H; Chen H; Liu J
Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between RARbeta gene promoter methylation and P53 gene mutations in non-small cell lung cancer].
Tan C; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Chen CM; Sun XY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):131-6. PubMed ID: 22487818
[TBL] [Abstract][Full Text] [Related]
13. Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis.
Sun Z; Liu G; Xu N
Thorac Cancer; 2019 Jan; 10(1):54-59. PubMed ID: 30390382
[TBL] [Abstract][Full Text] [Related]
14. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data.
Liu WJ; Tan XH; Guo BP; Ke Q; Sun J; Cen H
Asian Pac J Cancer Prev; 2013; 14(6):3719-24. PubMed ID: 23886171
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
Virmani AK; Rathi A; Zöchbauer-Müller S; Sacchi N; Fukuyama Y; Bryant D; Maitra A; Heda S; Fong KM; Thunnissen F; Minna JD; Gazdar AF
J Natl Cancer Inst; 2000 Aug; 92(16):1303-7. PubMed ID: 10944551
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
[TBL] [Abstract][Full Text] [Related]
17. The association between RARβ and FHIT promoter methylation and the carcinogenesis of patients with cervical carcinoma: A meta-analysis.
Shu R; He J; Wu C; Gao J
Tumour Biol; 2017 Jun; 39(6):1010428317709126. PubMed ID: 28639889
[TBL] [Abstract][Full Text] [Related]
18. Combined effects methylation of FHIT, RASSF1A and RARβ genes on non-small cell lung cancer in the Chinese population.
Li W; Deng J; Tang JX
Asian Pac J Cancer Prev; 2014; 15(13):5233-7. PubMed ID: 25040980
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS
Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007
[TBL] [Abstract][Full Text] [Related]
20. Gene promoter methylation and cancer: An umbrella review.
Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M
Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
